Christian Jackisch Selected Research

Noninfiltrating Intraductal Carcinoma (DCIS)

02/2006	C-KIT expression in ductal carcinoma in situ of the breast: co-expression with HER-2/neu.
03/2005	Androgen receptor expression in ductal carcinoma in situ of the breast: not a helpful marker for classification such as estrogen receptor alpha and progesterone receptor.
10/2004	Estrogen receptor alpha and beta, progesterone receptor, pS2 and HER-2/neu expression delineate different subgroups in ductal carcinoma in situ of the breast.

12	Breast Neoplasms (Breast Cancer) 04/2008 - 04/2002
4	Ovarian Neoplasms (Ovarian Cancer) 04/2007 - 09/2003
3	Noninfiltrating Intraductal Carcinoma (DCIS) 02/2006 - 10/2004
1	Neutropenia 11/2008
1	Carcinoma (Carcinomatosis) 01/2008
1	Neoplasms (Cancer) 08/2006

3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2008 - 10/2002
3	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2008 - 10/2002
3	docetaxel (Taxotere)FDA Link 04/2008 - 10/2002
3	Carboplatin (JM8)FDA LinkGeneric 10/2006 - 09/2003
2	PlatinumIBA 04/2007 - 10/2006
2	TANDEMIBA 08/2006 - 12/2005
2	Paclitaxel (Taxol)FDA LinkGeneric 08/2006 - 09/2003
2	trastuzumab (Herceptin)FDA Link 01/2006 - 10/2005
2	Estrogen Receptor alphaIBA 03/2005 - 10/2004
2	Progesterone Receptors (Progesterone Receptor)IBA 03/2005 - 10/2004
1	capecitabine (Xeloda)FDA Link 04/2008
1	vinorelbine (Navelbine)FDA LinkGeneric 04/2008
1	gefitinib (Iressa)FDA Link 04/2007
1	Tamoxifen FDA LinkGeneric 04/2007
1	taxaneIBA 04/2007
1	HormonesIBA 02/2007
1	Aromatase InhibitorsIBA 02/2007
1	gemcitabine FDA Link 10/2006
1	Topotecan (Hycamtin)FDA Link 08/2006
1	Carbon MonoxideIBA 02/2006
1	Androgen Receptors (Androgen Receptor)IBA 03/2005
1	Cisplatin (Platino)FDA LinkGeneric 09/2003
1	SiliconesIBA 04/2002